The U.S. Food and Drug Administration has approved a subcutaneous (SC) induction regimen of Tremfya (guselkumab) for the treatment of adults with moderately to severely active ulcerative colitis.
SurvivorNet on MSN
FDA Approves New Subcutaneous (Under-the-Skin) Option for Keytruda: What It Means for Cancer Patients
The U.S. Food and Drug Administration (FDA) has approved the subcutaneous form of Keytruda for a new 'Under-the-Skin' Option for patients. The subcutaneous form of Keytruda showed to deliver the same ...
MyChesCo on MSN
FDA Approves Johnson & Johnson’s Tremfya Subcutaneous Induction for Ulcerative Colitis
HORSHAM, PA — Johnson & Johnson (NYSE: JNJ) announced that the U.S. Food and Drug Administration has approved a subcutaneous induction regimen of TREMFYA (guselkumab) for the treatment of adults ...
The U.S. Department of Agriculture is developing a plan to revitalize the decimated U.S. beef herd, but will not offer payments to producers, Agriculture Secretary Brooke Rollins said on Thursday.
With new technologies coming out frequently that promise to help cattle producers improve their herd health and bottom line, it’s important to take a “systems thinking” approach to the options, ...
During Farm Safety week, John Currin, Virginia Tech Extension veterinarian, reminds us: “No matter how long we've done this, we can always learn to do things better. Be open and don't think you know ...
The agency found that Gallant’s data provides reasonable expectation of effectiveness.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results